Healio

Cardiac resynchronization therapy displays long-term benefits vs. ICD in HFrEF

Please provide your email address to receive an email when new articles are posted on . Long-term CRT-D use was tied to improved survival and time to adverse events vs. ICD therapy in patients with ...
Business Wire

LivaNova Announces the Launch of the PLATINIUM ICD & CRT-D Family Providing the World’s Longest Projected Longevity

PLATINIUM, released simultaneously in both Europe and Japan by LivaNova (formerly Sorin Group), will protect patients from avoidable replacement surgeries and the inherent risk of complications.
Nature

Should all patients with heart failure and left ventricular dysfunction receive combined CRT–ICD therapy?

Patients with heart failure (HF) and left ventricular (LV) dysfunction have been shown to derive clinical benefit from cardiac resynchronization therapy (CRT) and from implantable ...
Medical Xpress

Upgrade to cardiac resynchronization therapy benefits heart failure patients with pacing

Upgrade to cardiac resynchronization therapy with a defibrillator (CRT-D) reduces morbidity and mortality and improves left ventricular (LV) reverse remodeling compared to an implantable ...
Healio

Novel ICD platform may benefit patients with HFrEF at risk for sudden cardiac death

Please provide your email address to receive an email when new articles are posted on . A novel implantable cardioverter defibrillator platform may benefit patients with HF not eligible for cardiac ...
TCTMD

Upgrading to CRT Has Big Impact on HFrEF Patients With High RV Pacing Burden

AMSTERDAM, the Netherlands—Among patients with heart failure with reduced ejection fraction (HFrEF), a previously implanted pacemaker or ICD, and a significant RV pacing burden, upgrading to a cardiac ...
News Medical

CRT-D upgrade reduces morbidity and mortality in HFrEF patients with RV pacing

Upgrade to cardiac resynchronization therapy with a defibrillator (CRT-D) reduces morbidity and mortality and improves left ventricular (LV) reverse remodeling compared to an implantable ...
TCTMD

CRT-D Offers Persistent Survival Benefit in Long-term RAFT Results

The survival benefit of a cardiac resynchronization therapy-defibrillator (CRT-D) lasts for several years in patients with mild-to-moderate symptoms of heart failure (HF), a reduced ejection fraction, ...
Medscape

Heart Failure News

QRS Duration Found To Be Strong Predictor of Mortality Two recent studies add to the growing body of evidence suggesting QRS duration is an independent predictor of mortality; simple marker may help ...
Medscape

Effectiveness of Cardiac Resynchronization Therapy in Mild Congestive Heart Failure: Systematic Review and Meta-analysis of Randomized Trials

An electronic search of EMBASE and MEDLINE was performed for all English articles of human studies through July 2009 using the search terms 'CRT' OR 'CRT' OR 'biventricular pacing' OR 'biventricular ...
BioWorld

Abbott scoops up win at FDA for Gallant ICD, CRT-D devices

The U.S. FDA has given its nod to Abbott Laboratories' next-generation Gallant implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices. The ...